<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03638700</url>
  </required_header>
  <id_info>
    <org_study_id>39/16</org_study_id>
    <nct_id>NCT03638700</nct_id>
  </id_info>
  <brief_title>Comparison of Two High Performance Guidewires in ERCP</brief_title>
  <official_title>Comparison of the Use of Two High Performance Guidewires in Patients With Stenosis of the Bile Ducts in ERCP: A Randomised Multicenter Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Klinikum Stadt Hanau</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institutul Regional de Gastroenterologie &amp; Hepatologie Prof. dr. Octavian Fodor</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Robert Bosch Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In ERCP guidewires are used for the insertion of endoprostheses and the cannulation of
      stenosis. This leads to two essential requirements for the wire systems: The use of a
      (highly) flexible, hydrophilic wire to achieve successful and rapid passage of the narrow
      passage; for additional intervention, modern wires are equipped with a stable shaft with
      which e.g. bougies, dilatation catheters, or stents can be introduced. Guidewires are
      available with angled or straight tips whose use differ regionally. Guidewires with angled
      tips are used predominantly in Japan, whereas in the Western world incl. Germany straight
      wires are commonly used. In a recently published study examining the intubation of the native
      papilla, successful intubation of the papilla was faster with guidewires with angled tips
      than with guidewires with straight tips. However, this did not result in an effect upon the
      time-independent rate of the successful papilla intubation.

      The investigators test the hypothesis that 1) a higher success rate of the ERCP can be
      achieved with the use of an angled guidewire than with a straight guidewire and 2) a higher
      success rate of the ERCP can be achieved with the use of a type 1 guidewire than with a type
      2 guidewire
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, multicentric study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of successful passages of bilary (pancreatic) stenosis with the different guidewires.</measure>
    <time_frame>through study completion, an average of 2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of ERCP session</measure>
    <time_frame>through study completion, an average of 2 years</time_frame>
    <description>Comparison of time needed for the ERCP session in all study groups</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">680</enrollment>
  <condition>Stenosis of Bile Duct</condition>
  <arm_group>
    <arm_group_label>guidewire type 1: VisiGlide™ angled tip</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Primary use of VisiGlide™ guidewire (angled tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide™ (straight tip) resp. to VisiGlid2e™ (tip according to the examiner)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>guidewire type 2: VisiGlide2™ angled tip</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Primary use of VisiGlide2™ guidewire (straight tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide2™ (angled tip) resp. to VisiGlide™ (tip according to the examiner)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>guidewire type 1: VisiGlide™ straight tip</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Primary use of VisiGlide™ guidewire (straight tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide™ (angled tip) resp. to VisiGlide2™ (tip according to the examiner)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>guidewire type 2: VisiGlide2™ straight tip</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Primary use of VisiGlide2™ guidewire (straight tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide2™ (angled tip) resp. to VisiGlide™ (tip according to the examiner)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VisiGlide™ angled tip</intervention_name>
    <description>Arm A: Primary use of VisiGlide™ guidewire (angled tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide™ (straight tip) resp. to VisiGlid2e™ (tip according to the examiner)</description>
    <arm_group_label>guidewire type 1: VisiGlide™ angled tip</arm_group_label>
    <arm_group_label>guidewire type 1: VisiGlide™ straight tip</arm_group_label>
    <arm_group_label>guidewire type 2: VisiGlide2™ angled tip</arm_group_label>
    <arm_group_label>guidewire type 2: VisiGlide2™ straight tip</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VisiGlide2™ angled tip</intervention_name>
    <description>Arm B: Primary use of VisiGlide2™ guidewire (angled tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide2™ (straight tip) resp. to VisiGlide™ (tip according to the examiner)</description>
    <arm_group_label>guidewire type 1: VisiGlide™ angled tip</arm_group_label>
    <arm_group_label>guidewire type 1: VisiGlide™ straight tip</arm_group_label>
    <arm_group_label>guidewire type 2: VisiGlide2™ angled tip</arm_group_label>
    <arm_group_label>guidewire type 2: VisiGlide2™ straight tip</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VisiGlide™ straight tip</intervention_name>
    <description>Arm C: Primary use of VisiGlide™ guidewire (straight tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide™ (angled tip) resp. to VisiGlide2™ (tip according to the examiner)</description>
    <arm_group_label>guidewire type 1: VisiGlide™ angled tip</arm_group_label>
    <arm_group_label>guidewire type 1: VisiGlide™ straight tip</arm_group_label>
    <arm_group_label>guidewire type 2: VisiGlide2™ angled tip</arm_group_label>
    <arm_group_label>guidewire type 2: VisiGlide2™ straight tip</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VisiGlide2™ straight tip</intervention_name>
    <description>Arm D: Primary use of VisiGlide2™ guidewire (straight tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide2™ (angled tip) resp. to VisiGlide1™ (tip according to the examiner)</description>
    <arm_group_label>guidewire type 1: VisiGlide™ angled tip</arm_group_label>
    <arm_group_label>guidewire type 1: VisiGlide™ straight tip</arm_group_label>
    <arm_group_label>guidewire type 2: VisiGlide2™ angled tip</arm_group_label>
    <arm_group_label>guidewire type 2: VisiGlide2™ straight tip</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Obstruction of the biliary tract (cross sectional imaging or ultrasonography/lab data

        Exclusion Criteria:

          -  Operatively alternated anatomy of the patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jörg G Albert</last_name>
    <role>Principal Investigator</role>
    <affiliation>Robert Bosch Krankenhaus Stuttgart, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jörg G Albert</last_name>
    <email>Joerg.Albert@rbk.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Goethe University Hospital Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <state>Hessen</state>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joerg Albert, Prof.</last_name>
      <phone>+49 69 6301 5441</phone>
      <email>J.Albert@med.uni-frankfurt.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>June 13, 2016</study_first_submitted>
  <study_first_submitted_qc>August 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2018</study_first_posted>
  <last_update_submitted>August 17, 2018</last_update_submitted>
  <last_update_submitted_qc>August 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johann Wolfgang Goethe University Hospital</investigator_affiliation>
    <investigator_full_name>Jorg Albert</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>stenosis</keyword>
  <keyword>bile duct</keyword>
  <keyword>guidewire</keyword>
  <keyword>ercp</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

